col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


316 Results       Page 1

 [1] 
Elsevier: iScience
  original article Date Title Authors   All Authors
1 [GO] 2023―May―25 Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents Masaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, Takehisa Matsumoto, Chieko Makino-Okamura, Qingshun Lin, et al. (+23)
2 [GO] 2023―May―25 SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production Naomi Oka, Kazuya Shimada, Azusa Ishii, Nobuyuki Kobayashi, Kazuhiro Kondo
3 [GO] 2023―May―22 Exploring genetic associations between allergic diseases and indicators of COVID-19 using Mendelian randomization Yujie Wang, Xiaoyu Gu, Xinquan Wang, Wu Zhu, Juan Su
4 [GO] 2023―May―22 Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection. Martina Milighetti, Yanchun Peng, Cedric Tan, Michal Mark, Gayathri Nageswaran, Suzanne Byrne, et al. (+29)
5 [GO] 2023―May―21 Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations Camilla Tiezzi, Andrea Vecchi, Marzia Rossi, Davide Cavazzini, Angelo Bolchi, Diletta Laccabue, et al. (+24)
6 [GO] 2023―May―18 Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in severe patients with COVID-19 Xiaosheng Wu, Michelle K. Manske, Gordon J. Ruan, Taylor L. Witter, Kevin E. Nowakowski, Jithma P. Abeykoon, et al. (+13)
7 [GO] 2023―May―04 Diverged landscape of restaurant recovery from the COVID-19 pandemic in the United States Siqin Wang, Xiao Huang, Bing She, Zhenlong Li
8 [GO] 2023―May―04 Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers Christine Bäuerl, Joao Zulaica, Luciana Rusu, Alicia Rodríguez Moreno, Francisco J. Pérez-Cano, Carles Lerin, et al. (+6)
9 [GO] 2023―May―02 Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East Respiratory Syndrome Coronavirus infection Ethan J. Fritch, Wes Sanders, Amy C. Sims, Laura E. Herring, Natalie K. Barker, Athena A. Schepmoes, et al. (+9)
10 [GO] 2023―Apr―27 HLA Diversity across the HLA-DP locus is associated with improved response to SARS-CoV-2 vaccine in hematopoietic stem cell transplant recipients. Juliette Villemonteix, Vincent Allain, Emma Verstraete, Debora Jorge-Cordeiro, Gérard Socié, Alienor Xhaard, et al. (+2)
11 [GO] 2023―Apr―25 Randomized clinical trials of COVID-19 vaccines: do adenovirus-vector vaccines have beneficial non-specific effects? Christine S. Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, Mihai G. Netea, Peter Aaby
12 [GO] 2023―Apr―23 Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections Stefania Arsuffi, Emanuele Sansone, Emanuele Focà, Samuele Storti, Teresa Diaferia, Carlo Bonfanti, et al. (+6)
13 [GO] 2023―Apr―20 COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient Ryo Morita, Ritsuko Kubota-Koketsu, Xiuyuan Lu, Tadahiro Sasaki, Emi E. Nakayama, Yu-chen Liu, et al. (+11)
14 [GO] 2023―Apr―19 Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: implications for vaccine dose interval Sho Miyamoto, Yudai Kuroda, Takayuki Kanno, Akira Ueno, Nozomi Shiwa-Sudo, Naoko Iwata-Yoshikawa, et al. (+16)
15 [GO] 2023―Apr―12 Multiplexed On-Yeast Serological Assay for Immune Escape Screening of SARS-CoV-2 Variants Joanan Lopez-Morales, Rosario Vanella, Tamara Utzinger, Valentin Schittny, Julia Hirsiger, Michael Osthoff, et al. (+3)
16 [GO] 2023―Apr―10 Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus Da-Yuan Chen, Jacquelyn Turcinovic, Shuchen Feng, Devin J. Kenney, Chue Vin Chin, Manish C. Choudhary, et al. (+13)
17 [GO] 2023―Apr―09 The Human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein. Charles Zou, Hojong Yoon, Paul M.C. Park, J.J. Patten, Jesse Pellman, Jeannie Carreiro, et al. (+11)
18 [GO] 2023―Apr―08 Mycobacterium tuberculosis and SARS-CoV-2 co-infections: the knowns and unknowns Kim R. Chiok, Neeraj Dhar, Arinjay Banerjee
19 [GO] 2023―Apr―07 Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions Yannic C. Bartsch, Deniz Cizmeci, Jaewon Kang, Hailong Gao, Wei Shi, Abishek Chandrashekar, et al. (+4)
20 [GO] 2023―Apr―07 SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients Benjamin Charvet, Joanna Brunel, Justine Pierquin, Mathieu Iampietro, Didier Decimo, Nelly Queruel, et al. (+15)
21 [GO] 2023―Apr―01 19n01, a broadly neutralizing antibody against Omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern Melissa García-Vega, Edgar A. Melgoza-González, Sofía Hernández-Valenzuela, Diana Hinojosa-Trujillo, Mónica Reséndiz-Sandoval, Mara Anais Llamas-Covarrubias, et al. (+17)
22 [GO] 2023―Mar―28 COVID-19 Vaccine Antibody Responses in Community Dwelling Adults to 48 weeks Post Primary Vaccine Series Sharon L Walmsley, Leah Szadkowski, Bradly Wouters, Rosemarie Clarke, Karen Cowill, Paula Rochon, et al. (+14)
23 [GO] 2023―Mar―21 Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization Edwards Pradenas, Silvia Marfil, Víctor Urrea, Macedonia Trigueros, Tetyana Pidkova, Anna Pons-Grífols, et al. (+15)
24 [GO] 2023―Mar―15 A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease Alexandra Alvergne, Gabriella Kountourides, M. Austin Argentieri, Lisa Agyen, Natalie Rogers, Dawn Knight, et al. (+3)
25 [GO] 2023―Mar―15 Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 Omicron sub-lineages Franck Touret, Emilie Giraud, Jérôme Bourret, Flora Donati, Jaouen Tran-Rajau, Jeanne Chiaravalli, et al. (+5)
26 [GO] 2023―Mar―14 Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways Lihua Wang, Daniel Western, Jigyasha Timsina, Charlie Repaci, Won-Min Song, Joanne Norton, et al. (+16)
27 [GO] 2023―Mar―06 Changes in serum neutralizing antibody potency and breadth post SARS-CoV-2 mRNA vaccine boost Manoj S. Nair, Ruy M. Ribeiro, Maple Wang, Anthony D. Bowen, Lihong Liu, Yicheng Guo, et al. (+7)
28 [GO] 2023―Mar―02 Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the Sotrovimab face but is escaped by Omicron Jakob Kreye, S Momsen Reincke, Stefan Edelburg, Lara M Jeworowski, Hans-Christian Kornau, Jakob Trimpert, et al. (+19)
29 [GO] 2023―Feb―28 Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T-cells against SARS-CoV-2 variants Kate A. Parham, Gyoung Nyoun Kim, Connor G. Richer, Marina Ninkov, Kunyu Wu, Nasrin Saeedian, et al. (+7)
30 [GO] 2023―Feb―28 Coronavirus accessory protein ORF3 biology and its contribution to viral behavior and pathogenesis Fusheng Si, Shuai Song, Ruisong Yu, Zhen Li, Wenqiang Wei, Chao Wu
31 [GO] 2023―Feb―28 FDA-Approved Abl/EGFR/PDGFR Kinase Inhibitors Show Potent Efficacy Against Pandemic and Seasonal Influenza A Virus infections of human lung explants Robert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny Jonigk, et al. (+2)
32 [GO] 2023―Feb―27 Artificial Intelligence-based HDX (AI-HDX) Prediction Reveals Fundamental Characteristics to Protein Dynamics: Mechanisms on SARS-CoV-2 Immune Escape Jiali Yu, Ugur Uzuner, Bin Long, Zachary Wang, Joshua S Yuan, Susie Y Dai
33 [GO] 2023―Feb―25 Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization Debjani Pal, Kuntal De, Timothy B. Yates, Jaydeep Kolape, Wellington Muchero
34 [GO] 2023―Feb―22 Demultiplexing Ig repertoires by parallel mRNA/DNA sequencing shows major differential alterations in severe COVID-19 Virginie Pascal, Marine Dupont, Paco de Rouault, David Rizzo, Delphine Rossille, Robin Jeannet, et al. (+14)
35 [GO] 2023―Feb―21 Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2 Ruoxu Li, Ning Su, Xiaodong Ren, Xiange Sun, Wenman Li, Yuwei Li, et al. (+6)
36 [GO] 2023―Feb―20 Incorporation of SARS-CoV-2 spike NTD to RBD Protein Vaccine Improves Immunity Against Viral Variants Isabelle Montgomerie, Thomas W. Bird, Olga R. Palmer, Ngarangi C. Mason, Theresa E. Pankhurst, Blair Lawley, et al. (+19)
37 [GO] 2023―Feb―18 Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission Matthew Cotten, My V.T. Phan
38 [GO] 2023―Feb―16 Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene Kosuke Takada, Mahoko Takahashi Ueda, Shintaro Shichinohe, Yurie Kida, Chikako Ono, Yoshiharu Matsuura, et al. (+2)
39 [GO] 2023―Feb―15 SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021 Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, Paola Mariela Saba Villarroel, Elif Nurtop, Christine Isnard, et al. (+5)
40 [GO] 2023―Feb―10 SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection Allison Marie Greaney, Micha Sam Brickman Raredon, Maria P. Kochugaeva, Laura E. Niklason, Andre Levchenko
41 [GO] 2023―Feb―09 COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbionts William Parker, Esha Patel, Kateřina Jirků-Pomajbíková, Jon D. Laman
42 [GO] 2023―Feb―04 Probing the Affinity of Noble Metal Nanoparticles to the Segments of the SARS-CoV-2 Spike Protein Qiuyang Lu, Baiyang Zhang, Mingzi Sun, Lu Lu, Baian Chen, Hon Ho Wong, et al. (+3)
43 [GO] 2023―Feb―03 Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants Camille Chauvin, Laurine Levillayer, Mathilde Roumier, Hubert Nielly, Claude Roth, Anupama Karnam, et al. (+23)
44 [GO] 2023―Feb―02 Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, Mercè Roca, Eva Perozo Mur, Ricard March, et al. (+40)
45 [GO] 2023―Jan―31 Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy Takuya Tada, Belinda M. Dcosta, Hao Zhou, Nathaniel R. Landau
46 [GO] 2023―Jan―24 Targeting intracellular Neu1 for Coronavirus Infection Treatment Darong Yang, Yin Wu, Isaac Turan, Joseph Keil, Kui Li, Michael H. Chen, et al. (+4)
47 [GO] 2023―Jan―20 Omicron Mutations Increase Interdomain Interactions and Reduce Epitope Exposure in the SARS-CoV-2 Spike Miłosz Wieczór, Phu K. Tang, Modesto Orozco, Pilar Cossio
48 [GO] 2023―Jan―16 SARS-CoV-2 N protein mediates intercellular nucleic acid dispersion, a feature reduced in Omicron Jung-Lin Wu, I.-I. Kuan, Jing-You Guo, Wei-Chia Hsu, Wei-Chun Tang, Hsin-Ju Chan, et al. (+4)
49 [GO] 2023―Jan―13 Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization Sho Miyamoto, Takeshi Arashiro, Akira Ueno, Takayuki Kanno, Shinji Saito, Harutaka Katano, et al. (+13)
50 [GO] 2023―Jan―13 SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice Rute Gonçalves, Joana Couto, Pedro Ferreirinha, José Maria Costa, Diogo Silvério, Marta L. Silva, et al. (+5)
51 [GO] 2023―Jan―10 An inactivated SARS-CoV-2 vaccine induced cross-neutralising persisting antibodies and protected upon challenge in small animals Anna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, Pavel Marichal-Gallardo, Kenn Holmbeck, Anne Finne Pihl, et al. (+14)
52 [GO] 2023―Jan―07 Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform Denisa Bojkova, Philipp Reus, Leona Panosch, Marco Bechtel, Tamara Rothenburger, Joshua D. Kandler, et al. (+19)
53 [GO] 2023―Jan―05 Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region Marc Emmenegger, Elena De Cecco, David Lamparter, Raphaël P.B. Jacquat, Julien Riou, Dominik Menges, et al. (+58)
54 [GO] 2022―Dec―29 Extended SARS-CoV-2 mRNA vaccine prime-boost intervals enhances B cell immunity with limited impact on T cells Alexandre Nicolas, Gérémy Sannier, Mathieu Dubé, Manon Nayrac, Alexandra Tauzin, Mark M. Painter, et al. (+16)
55 [GO] 2022―Dec―28 Nonstructural protein 1 (nsp1) widespread RNA decay phenotype varies among Coronaviruses. Yahaira Bermudez, Jacob Miles, Mandy Muller
56 [GO] 2022―Dec―28 MultiOMICs landscape of SARS-CoV-2-induced host responses in human lung epithelial cells Sneha M. Pinto, Yashwanth Subbannayya, Hera Kim, Lars Hagen, Maria W. Górna, Anni I. Nieminen, et al. (+4)
57 [GO] 2022―Dec―26 Network analysis uncovers the communication structure of SARS-CoV-2 Spike protein identifying sites for immunogen design Pedro D. Manrique, Srirupa Chakraborty, Rory Henderson, Robert J. Edwards, Rachael Mansbach, Kien Nguyen, et al. (+6)
58 [GO] 2022―Dec―26 Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19 Louise Pierneef, Anouk van Hooij, Danielle de Jong, Elisa M. Tjon Kon Fat, Krista E. van Meijgaarden, Elisa Petruccioli, et al. (+48)
59 [GO] 2022―Dec―24 CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17)
60 [GO] 2022―Dec―24 Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles Emma Touizer, Aljawharah Alrubbayi, Rosemarie Ford, Noshin Hussain, Pehuén Pereyra Gerber, Hiu-Long Shum, et al. (+24)
61 [GO] 2022―Dec―09 Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD Yaozong Chen, Jérémie Prévost, Irfan Ullah, Hugo Romero, Veronique Lisi, William D. Tolbert, et al. (+35)
62 [GO] 2022―Dec―08 Engineering Probiotic-derived Outer Membrane Vesicles as Functional Vaccine Carriers to Enhance Immunity against SARS-CoV-2 Jing Wo, Zhao-Yong Lv, Jia-Nan Sun, Hao Tang, Nan Qi, Bang-Ce Ye
63 [GO] 2022―Dec―07 Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination Daryl Geers, Roos S.G. Sablerolles, Debbie van Baarle, Neeltje A. Kootstra, Wim J.R. Rietdijk, Katharina S. Schmitz, et al. (+18)
64 [GO] 2022―Dec―07 Stimulation of IFN-β responses by aberrant SARS-CoV-2 small viral RNAs acting as RIG-I agonists Yasuha Arai, Itaru Yamanaka, Toru Okamoto, Ayana Isobe, Naomi Nakai, Naoko Kamimura, et al. (+7)
65 [GO] 2022―Dec―06 Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome Kentaro Tojo, Natsuhiro Yamamoto, Nao Tamada, Takahiro Mihara, Miyo Abe, Mototsugu Nishii, et al. (+2)
66 [GO] 2022―Dec―05 Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape Roberta Marzi, Jessica Bassi, Chiara Silacci Fregni, Istvan Bartha, Francesco Muoio, Katja Culap, et al. (+33)
67 [GO] 2022―Dec―05 The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant Izumi Kimura, Daichi Yamasoba, Hesham Nasser, Jiri Zahradnik, Yusuke Kosugi, Jiaqi Wu, et al. (+20)
68 [GO] 2022―Dec―02 Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes Qian Wu, Naresh Kumar, William P. Lafuse, Omar Santiagonunez Ahumada, Noushin Saljoughian, Elizabeth Whetstone, et al. (+11)
69 [GO] 2022―Dec―01 mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 Omicron subvariants and other variants of concern Gang Wang, Juan Shi, Abhishek K. Verma, Xiaoqing Guan, Stanley Perlman, Lanying Du
70 [GO] 2022―Nov―30 Conformational stability of SARS-CoV-2 glycoprotein spike variants Hiam R.S. Arruda, Tulio M. Lima, Renata G.F. Alvim, Fernanda B.A. Victorio, Daniel P.B. Abreu, Federico F. Marsili, et al. (+9)
71 [GO] 2022―Nov―19 Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity Annika Nelde, Jonas Rieth, Malte Roerden, Marissa L. Dubbelaar, Naomi Hoenisch Gravel, Jens Bauer, et al. (+9)
72 [GO] 2022―Nov―16 Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models. Masaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, Takehisa Matsumoto, Chieko Makino-Okamura, Tomomi Uchikubo-Kamo, et al. (+25)
73 [GO] 2022―Nov―16 IMMUNE PROFILES TO DISTINGUISH HOSPITALIZED VERSUS AMBULATORY COVID-19 CASES IN OLDER PATIENTS Jéromine Klingler, Gregory S. Lambert, Juan C. Bandres, Rozita Emami-Gorizi, Arthur Nádas, Kasopefoluwa Y. Oguntuyo, et al. (+9)
74 [GO] 2022―Nov―13 Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells Taewoo Kim, Kyoung Il Min, Jeong-Sun Yang, Jun Won Kim, Junhyung Cho, Yun Ho Kim, et al. (+7)
75 [GO] 2022―Nov―11 Skewed Fate and Hematopoiesis of CD34+ HSPCs in Umbilical Cord Blood Amid the COVID-19 Pandemic Benjamin K. Estep, Charles J. Kuhlmann, Satoru Osuka, Gajendra W. Suryavanshi, Yoshiko Nagaoka-Kamata, Ciearria N. Samuel, et al. (+4)
76 [GO] 2022―Nov―07 Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population Lena Tschiderer, Lisa Seekircher, Lukas Richter, Dorothee von Laer, Cornelia Lass-Flörl, Lukas Forer, et al. (+7)
77 [GO] 2022―Nov―05 Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 Delta and beyond Hyung-Joon Kwon, Martina Kosikova, Weichun Tang, Uriel Ortega-Rodriguez, Peter Radvak, Ruoxuan Xiang, et al. (+16)
78 [GO] 2022―Nov―02 Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in Syrian hamster model Lunzhi Yuan, Huachen Zhu, Ming Zhou, Jian Ma, Xuan Liu, Kun Wu, et al. (+11)
79 [GO] 2022―Nov―02 Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice Feng-Xia Gao, Rui-Xin Wu, Mei-Ying Shen, Jing-Jing Huang, Ting-Ting Li, Chao Hu, et al. (+11)
80 [GO] 2022―Nov―01 Potent and biostable inhibitors of the main protease of SARS-CoV-2 Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, et al. (+19)
81 [GO] 2022―Oct―31 Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster Pai Peng, Cheng-qian Feng, Jie Hu, Chang-long He, Hai-jun Deng, Qing-hong Fan, et al. (+9)
82 [GO] 2022―Oct―30 Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells Jeffrey Arrindell, Perla Abou Atmeh, Laurie Jayet, Youssouf Sereme, Jean-Louis Mege, Benoit Desnues
83 [GO] 2022―Oct―28 Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals. Erola Ainsua-Enrich, Núria Pedreño-Lopez, Carmen Bracke, Carlos Ávila-Nieto, María Luisa Rodríguez de la Concepción, Edwards Pradenas, et al. (+26)
84 [GO] 2022―Oct―26 Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b Tránsito García-García, Raúl Fernández-Rodríguez, Natalia Redondo, Ana de Lucas-Rius, Sara Zaldívar-López, Blanca Dies López-Ayllón, et al. (+4)
85 [GO] 2022―Oct―25 Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants Hebah A. Al-Khatib, Maria K. Smatti, Fatma H. Ali, Hadeel T. Zedan, Swapna Thomas, Muna N. Ahmed, et al. (+7)
86 [GO] 2022―Oct―22 Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection Renxing Yi, Rina Hashimoto, Ayaka Sakamoto, Yasufumi Matsumura, Miki Nagao, Kazutoshi Takahashi, Kazuo Takayama
87 [GO] 2022―Oct―20 Swine Acute Diarrhea Syndrome Coronavirus Induces Autophagy to Promote Its Replication via the Akt/mTOR Pathway Siying Zeng, Yan Zhao, Ouyang Peng, Yu Xia, Qiuping Xu, Hongmei Li, et al. (+3)
88 [GO] 2022―Oct―20 Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity Akiho Yoshida, Shinya Okamura, Shiho Torii, Sayuri Komatsu, Paola Miyazato, Hitomi Sasaki, et al. (+8)
89 [GO] 2022―Oct―17 Susceptibility to SARS-CoV-2 Omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination Jia Xin Chua, Lindy Gillian Durrant, Yin Ling Chok, Oi Ming Lai
90 [GO] 2022―Oct―14 Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients Hye Kyung Lee, Ludwig Knabl, Mary Walter, Priscilla A. Furth, Lothar Hennighausen
91 [GO] 2022―Oct―13 Threats of COVID-19 arouse public awareness of climate change risks Yuanchao Gong, Yang Li, Linxiu Zhang, Tien Ming Lee, Yan Sun
92 [GO] 2022―Oct―13 Rational drug repositioning for coronavirus-associated diseases using directional mapping and side effect inference Jianhua Wang, Jiaojiao Liu, Menghan Luo, Hui Cui, Wenwen Zhang, Ke Zhao, et al. (+7)
93 [GO] 2022―Oct―12 Linking contact tracing with genomic surveillance to deconvolute SARS-CoV-2 transmission on a university campus Jacquelyn Turcinovic, Kayla Kuhfeldt, Madison Sullivan, Lena Landaverde, Judy T. Platt, Lynn Doucette-Stamm, et al. (+5)
94 [GO] 2022―Oct―10 LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19 Hideyuki Shimizu, Manabu Kodama, Masaki Matsumoto, Yasuko Orba, Michihito Sasaki, Akihiko Sato, et al. (+2)
95 [GO] 2022―Oct―10 Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19 Qiuchen Zhao, Zhenyang Yu, Shengyuan Zhang, Xu-Rui Shen, Hao Yang, Yangyang Xu, et al. (+14)
96 [GO] 2022―Oct―10 Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron Mehdi Benlarbi, Geneviève Laroche, Corby Fink, Kathy Fu, Rory P. Mulloy, Alexandra Phan, et al. (+15)
97 [GO] 2022―Oct―07 An overview and thematic analysis of research on cities and the COVID-19 pandemic: Toward just, resilient, and sustainable urban planning and design Ayyoob Sharifi
98 [GO] 2022―Oct―07 Host transcriptional responses in nasal swabs identifies potential SARS-CoV-2 infection in PCR negative patients Amanda M. Saravia-Butler, Jonathan C. Schisler, Deanne Taylor, Afshin Beheshti, Dan Butler, Cem Meydan, et al. (+5)
99 [GO] 2022―Oct―04 Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19 Young Erben, Mercedes Prudencio, Christopher P. Marquez, Karen R. Jansen-West, Michael G. Heckman, Launia J. White, et al. (+16)
100 [GO] 2022―Oct―04 Biparatopic nanobodies targeting the receptor binding domain efficiently neutralise SARS-CoV-2 Phillip Pymm, Samuel J. Redmond, Olan Dolezal, Francesca Mordant, Ester Lopez, James P. Cooney, et al. (+18)
101 [GO] 2022―Oct―02 Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses Kwiwan Jeong, Jinhee Kim, JuOae Chang, Subin Hong, Inseo Kim, Sunghyun Oh, et al. (+5)
102 [GO] 2022―Sep―28 Detecting time-evolving phenotypic components of adverse reactions against BNT162b2 mRNA SARS-CoV-2 vaccine via non-negative tensor factorization. Kei Ikeda, Taka-Aki Nakada, Takahiro Kageyama, Shigeru Tanaka, Naoki Yoshida, Tetsuo Ishikawa, et al. (+11)
103 [GO] 2022―Sep―23 Profiling of exhaled volatile organics in the screening scenario of a COVID-19 test center Rasmus Remy, Nele Kemnitz, Phillip Trefz, Patricia Fuchs, Julia Bartels, Ann-Christin Klemenz, et al. (+4)
104 [GO] 2022―Sep―23 Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to Variants of Concern Peifang Sun, Irene Ramos, Camila H. Coelho, Alba Grifoni, Corey A. Balinsky, Sindhu Vangeti, et al. (+20)
105 [GO] 2022―Sep―16 SARS-CoV-2 infection of human pluripotent stem cell-derived liver organoids reveals potential mechanisms of liver pathology Alexsia Richards, Max Friesen, Andrew Khalil, M. Inmaculada Barrasa, Lee Gehrke, Rudolf Jaenisch
106 [GO] 2022―Sep―09 Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection AH Ayesha Lavell, Jonne J. Sikkens, Arthur WD. Edridge, Karlijn van der Straten, Ferdyansyah Sechan, Melissa Oomen, et al. (+13)
107 [GO] 2022―Sep―06 CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry Elena-Sofia Heinl, Sebastian Lorenz, Barbara Schmidt, Nouf Nasser M Laqtom, Joseph R. Mazzulli, Laetitia Francelle, et al. (+11)
108 [GO] 2022―Sep―06 TEMPOL inhibits SARS-CoV-2 replication and development of lung disease in the Syrian hamster model Nunziata Maio, Sara Cherry, David C. Schultz, Brett L. Hurst, W. Marston Linehan, Tracey A. Rouault
109 [GO] 2022―Sep―05 Epidemiologic Information Discovery from Open-Access COVID-19 Case Reports via Pretrained Language Model Zhizheng Wang, Xiao Fan Liu, Zhanwei Du, Lin Wang, Ye Wu, Petter Holme, et al. (+5)
110 [GO] 2022―Sep―03 Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants Jing Xing, Rama Shankar, Meehyun Ko, Keke Zhang, Sulin Zhang, Aleksandra Drelich, et al. (+8)
111 [GO] 2022―Sep―03 The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling Emmanuel Laplantine, Christine Chable-Bessia, Anne Oudin, Jitendryia Swain, Adèle Soria, Peggy Merida, et al. (+15)
112 [GO] 2022―Sep―02 Obesity and metabolic dysfunction drive sex-associated differential disease profiles in hACE2-mice challenged with SARS-CoV-2 Katherine S. Lee, Brynnan P. Russ, Ting Y. Wong, Alexander M. Horspool, Michael T. Winters, Mariette Barbier, et al. (+4)
113 [GO] 2022―Sep―02 The mechanisms of immune response and evasion by the main SARS-CoV-2 variants Qiuli Chen, Jiawei Zhang, Peter Wang, Zuyong Zhang
114 [GO] 2022―Aug―31 Cystatin C is associated with adverse COVID-19 outcomes in diverse populations Sam O. Kleeman, Mattia Cordioli, Paul R.H. J. Timmers, Atlas Khan, Pinkus Tober-Lau, Florian Kurth, et al. (+8)
115 [GO] 2022―Aug―30 A Microarray Patch SARS-CoV-2 Vaccine Induces Sustained Antibody Responses and Polyfunctional Cellular Immunity Stephen C. Balmert, Zohreh Gholizadeh Ghozloujeh, Cara Donahue Carey, Li’an H. Williams, Jiying Zhang, Preeti Shahi, et al. (+5)
116 [GO] 2022―Aug―24 The amount of SARS-CoV-2 RNA in wastewater relates to the development of the pandemic and its burden on the health system Hao Wang, Marianela Patzi Churqui, Timur Tunovic, Lucica Enache, Anette Johansson, Ambjörn Kärmander, et al. (+7)
117 [GO] 2022―Aug―23 Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients Alexandra Tauzin, Guillaume Beaudoin-Bussières, Shang Yu Gong, Debashree Chatterjee, Gabrielle Gendron-Lepage, Catherine Bourassa, et al. (+14)
118 [GO] 2022―Aug―17 MedML: Fusing Medical Knowledge and Machine Learning Models for Early Pediatric COVID-19 Hospitalization and Severity Prediction Junyi Gao, Chaoqi Yang, Joerg Heintz, Scott Barrows, Elise Albers, Mary Stapel, et al. (+3)
119 [GO] 2022―Aug―17 SARS-CoV-2 specific CD4+ T cell longevity correlates with Th17-like phenotype Kazutaka Terahara, Takashi Sato, Yu Adachi, Keisuke Tonouchi, Taishi Onodera, Saya Moriyama, et al. (+9)
120 [GO] 2022―Aug―14 Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern Abigael E. Chaouat, Limor Kliker, Or Alfi, Michal Mandelboim, Dana Wolf, Laith Tafish, et al. (+3)
121 [GO] 2022―Aug―13 Host and microbiome features of secondary infections in lethal covid-19 Martin Zacharias, Karl Kashofer, Philipp Wurm, Peter Regitnig, Moritz Schütte, Margit Neger, et al. (+19)
122 [GO] 2022―Aug―13 Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization. J.J. Patten, Patrick T. Keiser, Deisy Morselli-Gysi, Giulia Menichetti, Hiroyuki Mori, Callie J. Donahue, et al. (+20)
123 [GO] 2022―Aug―11 TITLE: Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways Fangzhu Zhao, Celina Keating, Gabriel Ozorowski, Namir Shaabani, Irene M. Francino-Urdaniz, Shawn Barman, et al. (+17)
124 [GO] 2022―Aug―09 Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination Li-Jun Duan, Wen-Guo Jiang, Zhuang-Ye Wang, Lin Yao, Ka-Li Zhu, Qing-Chuan Meng, et al. (+4)
125 [GO] 2022―Aug―06 Impacts of the COVID-19 on all aircraft emissions of international routes in South America Qiang Cui, Yilin Lei, Ye Li, Peter F. Wanke
126 [GO] 2022―Aug―02 Increased induction of serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2 Juan Irure-Ventura, Elena González-López, Carolina Castro-Hernández, Emilio Rodrigo-Calabia, Milagros Heras-Vicario, Juan Carlos Ruiz San Millán, Marcos López-Hoyos
127 [GO] 2022―Aug―01 Elevation of Neural injury markers in Patients with Neurologic Sequelae after Hospitalization for SARS-CoV-2 Infection Michail Spanos, Sigal Shachar, Thadryan Sweeney, H. Immo Lehmann, Priyanka Gokulnath, Guoping Li, et al. (+7)
128 [GO] 2022―Jul―20 Potent and Broad Neutralization of SARS-CoV-2 Variants of Concern (VOCs) including Omicron Sub-lineages BA.1 and BA.2 by Biparatopic Human VH Domains Chuan Chen, James W. Saville, Michelle M. Marti, Alexandra Schäfer, Mary Hongying Cheng, Dhiraj Mannar, et al. (+23)
129 [GO] 2022―Jul―16 Procedure room innovation during the COVID-19 crisis: Protecting healthcare workers while learning from history Dinesh Vyas, Kayla K. Umemoto, Arpita Vyas, Deepak L. Bhatt
130 [GO] 2022―Jul―16 Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, Sean R.A. Devenish, Alexey S. Morgunov, Alison Ilsley, et al. (+12)
131 [GO] 2022―Jul―14 SARS-CoV-2 Delta Spike Protein Enhances the Viral Fusogenicity and Inflammatory Cytokine Production Zhujun Ao, Maggie Jing Ouyang, Titus Abiola Olukitibi, Xiaojian Yao
132 [GO] 2022―Jul―11 Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants Flavia Chiuppesi, John A. Zaia, Katelyn Faircloth, Daisy Johnson, Minh Ly, Veronica Karpinski, et al. (+15)
133 [GO] 2022―Jul―09 Protein-protein conjugation enhances immunogenicity of SARS-CoV-2 Receptor Binding Domain (RBD) vaccines Puthupparampil V. Scaria, Chris G. Rowe, Beth B. Chen, Thayne H. Dickey, Jonathan P. Renn, Lynn E. Lambert, et al. (+4)
134 [GO] 2022―Jul―05 Vaccination with a bacterial peptide conjugated to SARS-CoV-2 RBD accelerates immunity and protects against COVID-19 Athanasios Blanas, Haiko Karsjens, Aafke de Ligt, Elisabeth J.M. Huijbers, Karlijn van Loon, Stepan Denisov, et al. (+7)
135 [GO] 2022―Jul―04 Immune response to SARS-CoV-2 in severe disease and long COVID-19 Tomonari Sumi, Kouji Harada
136 [GO] 2022―Jul―04 Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking Chih-Feng Tien, Wan-Ting Tsai, Chun Hwa Chen, Hui-Ju Chou, Mingzi M. Zhang, Jhe-Jhih Lin, et al. (+8)
137 [GO] 2022―Jul―04 Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Dominique Van Looveren, et al. (+20)
138 [GO] 2022―Jul―04 Trimeric Receptor Binding Domain of SARS-CoV-2 Acts as a Potent Inhibitor of ACE2 Receptor-Mediated Viral Entry Shrikanth C. Basavarajappa, Angela Rose Liu, Anna Bruchez, Zhenlu Li, Vinicius G. Suzart, Zhonghua Liu, et al. (+4)
139 [GO] 2022―Jul―04 Progressive membrane binding mechanism of SARS-CoV-2 variant spike proteins Michael Overduin, Troy A. Kervin, Anh Tran
140 [GO] 2022―Jun―30 Immunomodulatory LncRNA on Antisense Strand of ICAM-1 Augments SARS-CoV-2 Infection-associated Airway Mucoinflammatory Phenotype Dinesh Devadoss, Arpan Acharya, Marko Manevski, Dominika Houserova, Michael D. Cioffi, Kabita Pandey, et al. (+6)
141 [GO] 2022―Jun―20 The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex Limei Zou, Clara Moch, Marc Graille, Clément Chapat
142 [GO] 2022―Jun―17 Integrative Metabolomic and Proteomic Signatures Define Clinical Outcomes in Severe COVID-19 Mustafa Buyukozkan, Sergio Alvarez-Mulett, Alexandra C. Racanelli, Frank Schmidt, Richa Batra, Katherine L. Hoffman, et al. (+17)
143 [GO] 2022―Jun―16 SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis Wojciech J. Szlachcic, Agnieszka Dabrowska, Aleksandra Milewska, Natalia Ziojla, Katarzyna Blaszczyk, Emilia Barreto-Duran, et al. (+7)
144 [GO] 2022―Jun―15 Optimal vaccine roll-out strategies including social distancing for pandemics Konstantinos Spiliotis, Constantinos Chr. Koutsoumaris, Andreas I. Reppas, Lito A. Papaxenopoulou, Jens Starke, Haralampos Hatzikirou
145 [GO] 2022―Jun―15 Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways Daniel Richard, Pushpanathan Muthuirulan, Jennifer Aguiar, Andrew C. Doxey, Arinjay Banerjee, Karen Mossman, et al. (+2)
146 [GO] 2022―Jun―11 Sustainable social development promotes COVID-19 pandemic control Shilan Feng, Yingjia Zhai, Wendong Wei, Ya Tan, Yong Geng, Weiye Nie
147 [GO] 2022―Jun―03 VE607 Stabilizes SARS-CoV-2 Spike In the “RBD-up” Conformation and Inhibits Viral Entry Shilei Ding, Irfan Ullah, Shang Yu Gong, Jonathan Grover, Mohammadjavad Mohammadi, Yaozong Chen, et al. (+16)
148 [GO] 2022―Jun―02 Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2 Bo Wang, Eric R. Gamazon
149 [GO] 2022―May―31 Machine learning of COVID-19 clinical data identifies population structures with therapeutic potential David Greenwood, Tom Taverner, Nicola J. Adderley, Malcolm Price, Krishna Gokhale, Chris Sainsbury, et al. (+9)
150 [GO] 2022―May―30 Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data Daniele Ramazzotti, Davide Maspero, Fabrizio Angaroni, Silvia Spinelli, Marco Antoniotti, Rocco Piazza, Alex Graudenzi
151 [GO] 2022―May―25 Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection Dylan Sheerin, Nashied Peton, William Vo, Cody Charles Allison, Xutao Wang, W. Evan Johnson, Anna Kathleen Coussens
152 [GO] 2022―May―25 Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir treated rhesus macaques Ashish Goyal, Elizabeth R. Duke, E. Fabian Cardozo-Ojeda, Joshua T. Schiffer
153 [GO] 2022―May―23 The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro Lehtinen Markus J, Kumar Ritesh, Zabel Bryan, Mäkelä Sanna M, Nedveck Derek, Tang Peipei, et al. (+3)
154 [GO] 2022―May―23 COH04S1 and Beta Sequence Modified Vaccine Protect Hamsters From SARS-CoV-2 Variants Felix Wussow, Mindy Kha, Katelyn Faircloth, Vu H. Nguyen, Angelina Iniguez, Joy Martinez, et al. (+7)
155 [GO] 2022―May―19 Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants Yaning Li, Qing Fan, Bing Zhou, Yaping Shen, Yuanyuan Zhang, Lin Cheng, et al. (+6)
156 [GO] 2022―May―18 Pearson’s patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Huiling Luo, Fang Fang, et al. (+8)
157 [GO] 2022―May―04 SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters Zhendong Guo, Cheng Zhang, Chunmao Zhang, Huan Cui, Zhaoliang Chen, Xinyun Jiang, et al. (+8)
158 [GO] 2022―Apr―28 EVIDENCE SHOWING LIPOTOXICITY WORSENS OUTCOMES IN COVID-19 PATIENTS AND INSIGHTS ABOUT THE UNDERLYING MECHANISMS Rodrigo Cartin-Ceba, Biswajit Khatua, Bara El-Kurdi, Shubham Trivedi, Sergiy Kostenko, Zaid Imam, et al. (+16)
159 [GO] 2022―Apr―27 Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection Qiqi Zeng, Xin Qi, Junpeng Ma, Fang Hu, Xiaorui Wang, Hongyu Qin, et al. (+20)
160 [GO] 2022―Apr―26 The effect of the Delta SARS-CoV-2 variant in maternal infection and pregnancy Athina Samara, Asma Khalil, Patrick O’ Brien, Eric Herlenius
161 [GO] 2022―Apr―25 Inhibitors of dihydroorotate dehydrogenase cooperate with Molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication Kim M. Stegmann, Antje Dickmanns, Natalie Heinen, Claudia Blaurock, Tim Karrasch, Angele Breithaupt, et al. (+19)
162 [GO] 2022―Apr―11 Synthetic Carbohydrate Binding Agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2. Oscar Francesconi, Lorena Donnici, Marco Fragai, Elisa Pesce, Mauro Bombaci, Alessandra Fasciani, et al. (+6)
163 [GO] 2022―Apr―11 Inflammatory Responses in the Placenta upon SARS-CoV-2 Infection Late in Pregnancy Lissenya B. Argueta, Lauretta A. Lacko, Yaron Bram, Takuya Tada, Lucia Carrau, André Figueiredo Rendeiro, et al. (+20)
164 [GO] 2022―Apr―08 The value of longitudinal clinical data and paired CT scans in predicting the deterioration of COVID-19 revealed by an artificial intelligence system Xiaoyang Han, Ziqi Yu, Yaoyao Zhuo, Botao Zhao, Yan Ren, Lorenz Lamm, et al. (+6)
165 [GO] 2022―Apr―04 Unraveling the motivational secrets of honey bee foraging during the COVID pandemic Louise Bestea, Marco Paoli, Patrick Arrufat, Brice Ronsin, Julie Carcaud, Jean-Christophe Sandoz, et al. (+3)
166 [GO] 2022―Apr―02 Poly(I:C) Enhances Mesenchymal Stem Cell Control of Myeloid Cells From COVID-19 Patients Luciana Souza-Moreira, Yuan Tan, Yan Wang, Jia-Pey Wang, Mahmoud Salkhordeh, Jennifer Virgo, et al. (+7)
167 [GO] 2022―Mar―26 Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil Tiago Gräf, Gonzalo Bello, Felipe Gomes Naveca, Marcelo Gomes, Vanessa Leiko Oikawa Cardoso, Alexandre Freitas da Silva, et al. (+13)
168 [GO] 2022―Mar―22 Identified human breastmilk compositions effectively inhibit SARS-CoV-2 and variants infection and replication Xinyuan Lai, Yanying Yu, Wei Xian, Fei Ye, Xiaohui Ju, Yuqian Luo, et al. (+8)
169 [GO] 2022―Mar―17 Computed Tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates Thibaut Naninck, Nidhal Kahlaoui, Julien Lemaitre, Pauline Maisonnasse, Antoine De Mori, Quentin Pascal, et al. (+14)
170 [GO] 2022―Mar―17 Mono- and combinational drug therapies for global viral pandemic preparedness Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, Vegard Myhre, Erlend Ravlo, Gerda D. Kaynova, et al. (+12)
171 [GO] 2022―Mar―14 Association of high SARS-CoV-2 RNAemia with diabetes and mortality in COVID-19 critically ill patient. Mehran Monchi, Thomas Bruneau, Sebastien Jochmans, David Veyer, Aurelia Pitsch, Olivier Ellrodt, et al. (+6)
172 [GO] 2022―Mar―11 RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants Qingtai Liang, Yifeng Wang, Shuyuan Zhang, Jing Sun, Wenbo Sun, Jizhou Li, et al. (+21)
173 [GO] 2022―Mar―11 Detection of SARS-CoV-2 with RAPID: a prospective cohort study Marcelo D.T. Torres, Lucas F. de Lima, André L. Ferreira, William R. de Araujo, Paul Callahan, Antonio Dávila, et al. (+2)
174 [GO] 2022―Mar―10 ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis Jinhuan Wei, Rui Shang, Jiaqi Wang, Shengze Zhu, JianQiang Yin, Ying Chen, et al. (+2)
175 [GO] 2022―Mar―07 An artificial intelligence deep learning platform achieves high diagnostic accuracy for Covid-19 pneumonia by reading chest X-ray images Dongguang Li, Shaoguang Li
176 [GO] 2022―Feb―26 When do children avoid infection risks: Lessons for schools during the COVID-19 pandemic Nina H. Fefferman, Katy-Ann Blacker, Charles A. Price, Vanessa LoBue
177 [GO] 2022―Feb―23 Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern Anuradha Rao, Leda Bassit, Jessica Lin, Kiran Verma, Heather B. Bowers, Kimberly Pachura, et al. (+10)
178 [GO] 2022―Feb―23 Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19 Jun Wang, Prasanti Kotagiri, Paul A. Lyons, Rafia S. Al-Lamki, Federica Mescia, Laura Bergamaschi, et al. (+28)
179 [GO] 2022―Feb―22 Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses Zhao Ni Wang, Xiang Sheng Yang, Jing Sun, Jin Cun Zhao, Nan Shan Zhong, Xiao Xiao Tang
180 [GO] 2022―Feb―22 A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants Jules B. Weinstein, Timothy A. Bates, Hans C. Leier, Savannah K. McBride, Eric Barklis, Fikadu G. Tafesse
181 [GO] 2022―Feb―19 No substantial pre-existing B cell immunity against SARS-CoV-2 in healthy adults Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, Nareshkumar Poopalasingam, Susanne Detmer, Manuel Koch, et al. (+14)
182 [GO] 2022―Feb―17 Impact of New Variants on SARS-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions Mary Hongying Cheng, James M. Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, et al. (+2)
183 [GO] 2022―Feb―17 SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response Chanchan Xiao, Lipeng Mao, Zhigang Wang, Lijuan Gao, Guodong Zhu, Jun Su, et al. (+12)
184 [GO] 2022―Feb―12 Modeling potential impact of COVID-19 pandemic on global electric vehicle supply chain Xin Sun, Gang Liu, Han Hao, Zongwei Liu, Fuquan Zhao
185 [GO] 2022―Feb―05 Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa Olayinka Sunday Okoh, Nicholas Israel Nii-Trebi, Abdulrokeeb Jakkari, Tosin Titus Olaniran, Tosin Yetunde Senbadejo, Anna Aba Kafintu-kwashie, et al. (+10)
186 [GO] 2022―Feb―02 HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19 Liqun Zhang, Santosh K. Ghosh, Shrikanth C. Basavarajappa, Yinghua Chen, Pravesh Shrestha, Jackson Penfield, et al. (+4)
187 [GO] 2022―Jan―31 The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates the immunoregulatory/inflammatory signals Veronica Bordoni, Giulia Matusali, Davide Mariotti, Manuela Antonioli, Eleonora Cimini, Alessandra Sacchi, et al. (+9)
188 [GO] 2022―Jan―30 CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus Kazuto Yoshimi, Kohei Takeshita, Seiya Yamayoshi, Satomi Shibumura, Yuko Yamauchi, Masaki Yamamoto, et al. (+3)
189 [GO] 2022―Jan―28 Attenuation of SARS-CoV-2 Infection by Losartan in Human Kidney Organoids Waleed Rahmani, Hyunjae Chung, Sarthak Sinha, Maxwell Bui-Marinos, Rohit Arora, Arzina Jaffer, et al. (+3)
190 [GO] 2022―Jan―10 Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19. Nikhil Shri Sahajpal, Chi-Yu Jill Lai, Alex Hastie, Ashis K. Mondal, Siavash Raeisi Dehkordi, Caspar I. van der Made, et al. (+20)
191 [GO] 2022―Jan―07 Immunity to SARS-CoV-2 up to 15 months after infection Harold Marcotte, Antonio Piralla, Fanglei Zuo, Likun Du, Irene Cassaniti, Hui Wan, et al. (+27)
192 [GO] 2022―Jan―05 Neutralization of SARS-CoV-2 Delta variant is increased after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination Markus Bauswein, David Peterhoff, Annelie Plentz, Andreas Hiergeist, Ralf Wagner, André Gessner, et al. (+3)
193 [GO] 2022―Jan―01 SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics Karthik Ramachandran, Soumya Maity, Alagar R. Muthukumar, Soundarya Kandala, Dhanendra Tomar, Tarek Mohamed Abd El-Aziz, et al. (+16)
194 [GO] 2021―Dec―31 ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection Zai Wang, Tingting Deng, Yulian Zhang, Wenquan Niu, Qiangqiang Nie, Shengnan Yang, et al. (+5)
195 [GO] 2021―Dec―24 Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection Qi Cui, Gustavo Garcia, Mingzi Zhang, Cheng Wang, Hongzhi Li, Tao Zhou, et al. (+3)
196 [GO] 2021―Dec―24 Humoral and Cellular Immunogenicity two months after SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer Natacha Bordry, Alfredo Addeo, Cyril Jaksic, Valérie Dutoit, Pascale Roux-Lombard, Dimpy P. Shah, et al. (+13)
197 [GO] 2021―Dec―20 Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19 Julie C. Wilson, David Kealy, Sally R. James, Tobias Plowman, Katherine Newling, Christopher Jagger, et al. (+15)
198 [GO] 2021―Dec―20 ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 Naoki Iwanaga, Laura Cooper, Lijun Rong, Nicholas J. Maness, Brandon Beddingfield, Zhongnan Qin, et al. (+13)
199 [GO] 2021―Dec―20 Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, et al. (+8)
200 [GO] 2021―Dec―10 Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike Bailey Lubinski, Maureen H.V. Fernandes, Laura Frazier, Tiffany Tang, Susan Daniel, Diego G. Diel, et al. (+2)
201 [GO] 2021―Dec―09 Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults Mònica Girona-Alarcon, Guillermo Argüello, Ana Esteve-Sole, Sara Bobillo-Perez, Xavier Paolo-Burgos, Elisenda Bonet-Carne, et al. (+6)
202 [GO] 2021―Dec―08 Standardized two-step testing of antibody activity in COVID-19 convalescent plasma Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, et al. (+16)
203 [GO] 2021―Dec―04 SARS-CoV-2 Nucleocapsid protein attenuates stress granules and interacts with mRNAs to impair host stress response Syed Nabeel-Shah, Hyunmin Lee, Nujhat Ahmed, Giovanni L. Burke, Shaghayegh Farhangmehr, Kanwal Ashraf, et al. (+10)
204 [GO] 2021―Dec―03 Global Changes in Electricity Consumption During COVID-19 Elizabeth Buechler, Siobhan Powell, Tao Sun, Nicolas Astier, Chad Zanocco, Jose Bolorinos, et al. (+3)
205 [GO] 2021―Dec―03 Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication Elizabeth Geerling, Amanda N. Pinski, Taylor E. Stone, Richard J. DiPaolo, Michael Z. Zulu, Kevin J. Maroney, et al. (+3)
206 [GO] 2021―Dec―02 Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2 Srinivasulu Yerukala Sathipati, Sanjay K. Shukla, Shinn-Ying Ho
207 [GO] 2021―Nov―27 A Deep Learning Approach for Predicting Severity of COVID-19 Patients Using A Parsimonious Set of Laboratory Markers Vivek Singh, Rishi Kamaleswaran, Donald Chalfin, Antonio Buño-Soto, Janika San Roman, Edith Rojas-Kenney, et al. (+5)
208 [GO] 2021―Nov―27 Host parameters and mode of infection influence outcome in SARS-CoV-2 infected hamsters Bryan D. Griffin, Bryce M. Warner, Mable Chan, Emelissa Valcourt, Nikesh Tailor, Logan Banadyga, et al. (+23)
209 [GO] 2021―Nov―19 Pannexin-1 channel opening is critical for COVID-19 pathogenesis Ross Luu, Silvana Valdebenito, Eliana Scemes, Antonio Cibelli, David Spray, Maximiliano Rovegno, et al. (+11)
210 [GO] 2021―Nov―18 Fluvastatin mitigates SARS-CoV-2 infection in human lung cells Francisco J. Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, Marco van Ham, Miriam Becker, Graham Brogden, et al. (+11)
211 [GO] 2021―Nov―18 Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring towards glycolysis Hadar Medini, Amit Zirman, Dan Mishmar
212 [GO] 2021―Nov―17 Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2 Junpei Ohtsuka, Masaki Imai, Masayuki Fukumura, Mitsuyo Maeda, Asami Eguchi, Ryoichi Ono, et al. (+6)
213 [GO] 2021―Nov―11 Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, et al. (+9)
214 [GO] 2021―Nov―11 Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors Lei Guo, Yan Liang, Heng Li, Huiwen Zheng, Zening Yang, Yanli Chen, et al. (+6)
215 [GO] 2021―Nov―10 Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells Ria Goswami, Veronica S. Russell, Joshua J. Tu, Charlene Thomas, Philip Hughes, Francine Kelly, et al. (+6)
216 [GO] 2021―Nov―01 Functional differences among the spike glycoproteins of multiple emerging SARS-CoV-2 variants of concern Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, et al. (+3)
217 [GO] 2021―Oct―28 The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells Thushan I. de Silva, Guihai Liu, Benjamin B. Lindsey, Danning Dong, Shona C. Moore, Nienyun Sharon Hsu, et al. (+16)
218 [GO] 2021―Oct―25 Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19 Christoph Schultheiß, Lisa Paschold, Edith Willscher, Donjete Simnica, Anna Wöstemeier, Franziska Muscate, et al. (+6)
219 [GO] 2021―Oct―25 Partial Resistance of SARS-CoV-2 Delta Variants to Vaccine-elicited Antibodies and Convalescent sera Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau
220 [GO] 2021―Oct―25 DCcov: Repositioning of Drugs and Drug Combinations for SARS-CoV-2 Infected Lung through Constraint-Based Modeling Ali Kishk, Maria Pires Pacheco, Thomas Sauter
221 [GO] 2021―Oct―25 Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency Luis Eduardo R. Cunha, Adilson A. Stolet, Marcelo A. Strauch, Victor A.R. Pereira, Carlos H. Dumard, Andre M.O. Gomes, et al. (+27)
222 [GO] 2021―Oct―22 Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants Eva Lopez, Margot Barthélémy, Cécile Baronti, Shirley Masse, Alessandra Falchi, Fabien Durbesson, et al. (+4)
223 [GO] 2021―Oct―19 Effective chimeric antigen receptor T-cells (CAR-Ts) against SARS-CoV-2 Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H. Uri Saragovi, Christopher E. Rudd
224 [GO] 2021―Oct―16 Increased gaze cueing of attention during COVID-19 lockdown Mario Dalmaso, Luigi Castelli, Giovanni Galfano
225 [GO] 2021―Oct―14 The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor Chuncui Huang, Zeshun Tan, Keli Zhao, Wenjun Zou, Hui Wang, Huanyu Gao, et al. (+4)
226 [GO] 2021―Oct―08 Inequitable and Heterogeneous Impacts on Electricity Consumption from COVID-19 Mitigation Measures Jiehong Lou, Yueming (Lucy) Qiu, Arthur Lin Ku, Destenie Nock, Bo Xing
227 [GO] 2021―Oct―07 Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease Bryce M. Warner, Lisa A. Santry, Alexander Leacy, Mable Chan, Phuc H. Pham, Robert Vendramelli, et al. (+26)
228 [GO] 2021―Oct―04 6-Thioguanine Blocks SARS-CoV-2 Replication by Inhibition of PLpro Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, Xu Zhao, Larissa A. Canadeo, Houda H. Harastani, et al. (+5)
229 [GO] 2021―Oct―04 The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery. Eleni Syrimi, Eanna Fennell, Alex Richter, Pavle Vrljicak, Richard Stark, Sascha Ott, et al. (+17)
230 [GO] 2021―Sep―30 A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19 Friederike Krempe, Lara Schöler, Benjamin Katschinski, Anke Herrmann, Olympia E. Anastasiou, Carina Elsner, et al. (+6)
231 [GO] 2021―Sep―30 Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19 Na Wang, Marta Vuerich, Ahmadreza Kalbasi, Jonathon J. Graham, Eva Csizmadia, Zachary James Manickas Hill, et al. (+8)
232 [GO] 2021―Sep―30 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Huanhuan Zhu, Fang Zheng, Linxuan Li, Yan Jin, Yuxue Luo, Zhen Li, et al. (+19)
233 [GO] 2021―Sep―29 SARS-CoV-2 integral membrane proteins shape the serological responses of COVID-19 patients. Sophie Martin, Christopher Heslan, Gwénaële Jégou, Leif A. Eriksson, Matthieu Le Gallo, Vincent Thibault, et al. (+3)
234 [GO] 2021―Sep―27 The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium Jeong Yeon Ji, Ara Jo, Jina Won, Chan Hee Gil, Haeun Shin, Sujin Kim, et al. (+2)
235 [GO] 2021―Sep―16 The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, Peter AC. Wing, Mirjam Schilling, James M. Harris, et al. (+21)
236 [GO] 2021―Sep―11 5-Hydroxymethyltubercidin Exhibits Potent Antiviral Activity against Flaviviruses and Coronaviruses, including SARS-CoV-2 Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Takao Sanaki, Shinsuke Toba, Michihito Sasaki, et al. (+9)
237 [GO] 2021―Sep―10 An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses Kang Jin, Eric E. Bardes, Alexis Mitelpunkt, Jake Y. Wang, Surbhi Bhatnagar, Soma Sengupta, et al. (+3)
238 [GO] 2021―Sep―02 Development of humoral and cellular immunological memory against SARS-CoV-2 despite B-cell depleting treatment in multiple sclerosis. Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, Anna Månberg, Sophia Hober, Guro Gafvelin, et al. (+6)
239 [GO] 2021―Aug―31 One common enemy, a pandemic, uniting interdisciplinary teams Marie-Elizabeth Barabas, Rituparna Chakrabarti, Michelle Muzzio
240 [GO] 2021―Aug―26 Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 Xingyue An, Melisa Martinez-Paniagua, Ali Rezvan, Samiur Rahman Sefat, Mohsen Fathi, Shailbala Singh, et al. (+5)
241 [GO] 2021―Aug―26 A randomized trial of icosapent ethyl in ambulatory patients with COVID-19 Andrew Kosmopoulos, Deepak L. Bhatt, Gus Meglis, Raj Verma, Yi Pan, Adrian Quan, et al. (+26)
242 [GO] 2021―Aug―25 Single Cell Transcriptome Identifies FCGR3B Upregulated Subtype of Alveolar Macrophages in Patients with Critical COVID-19 Nasna Nassir, Richa Tambi, Asma Bankapur, Saba Al Heialy, Noushad Karuvantevida, Hamdah Hassan Khansaheb, et al. (+24)
243 [GO] 2021―Aug―20 Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern Juanjie Tang, Youri Lee, Supriya Ravichandran, Gabrielle Grubbs, Chang Huang, Charles B. Stauft, et al. (+4)
244 [GO] 2021―Aug―11 Distinct Lipid Metabolic Dysregulation in Asymptomatic COVID-19 Yanhong Hao, Zheng Zhang, Guifang Feng, Moran Chen, Qiongqiong Wan, Jie Lin, et al. (+3)
245 [GO] 2021―Aug―09 Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin Bin Guan, Karen M. Frank, José O. Maldonado, Margaret Beach, Eileen Pelayo, Blake M. Warner, Robert B. Hufnagel
246 [GO] 2021―Aug―04 Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 Jun-Guy Park, Fatai S. Oladunni, Mohammed A. Rohaim, Jayde Whittingham-Dowd, James Tollitt, Matthew D.J. Hodges, et al. (+13)
247 [GO] 2021―Jul―31 Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms Juan Manuel Carreño, Damodara Rao Mendu, Viviana Simon, Masood A. Shariff, Gagandeep Singh, Vidya Menon, Florian Krammer
248 [GO] 2021―Jul―30 JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules Jakub Jankowski, Hye Kyung Lee, Julia Wilflingseder, Lothar Hennighausen
249 [GO] 2021―Jul―26 A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes Daniel Todt, Toni Luise Meister, Barbora Tamele, John Howes, Dajana Paulmann, Britta Becker, et al. (+12)
250 [GO] 2021―Jul―22 Effect of time and titer in convalescent plasma therapy for COVID-19 Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Rosalba La Grotta, Annunziata De Rosa, Agostina Pontarelli, et al. (+3)
251 [GO] 2021―Jul―21 A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples Tiantian Liu, Zhong Chen, Wanqiu Chen, Xin Chen, Maryam Hosseini, Zhaowei Yang, et al. (+6)
252 [GO] 2021―Jul―14 The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir Yan Zhao, Jing Sun, Yunfei Li, Zhengxuan Li, Yu Xie, Ruoqing Feng, et al. (+2)
253 [GO] 2021―Jul―10 Sensor Array and Gas Chromatographic Detection of the Blood Serum Volatolomic Signature of COVID-19 Yolande Ketchanji Mougang, Lorena Di Zazzo, Marilena Minieri, Rosamaria Capuano, Alexandro Catini, Jacopo Maria Legramente, et al. (+3)
254 [GO] 2021―Jul―09 Multi-Omics analysis of respiratory specimen characterizes baseline molecular determinants which associate with SARS-CoV-2 infection and outcome. Jaswinder Singh Maras, Shvetank Sharma, Adil Bhat, Sheetalnath Rooge, Reshu aggrawal, Ekta Gupta, Shiv K. Sarin
255 [GO] 2021―Jun―26 Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2 Flavio De Maio, Valentina Palmieri, Gabriele Babini, Alberto Augello, Ivana Palucci, Giordano Perini, et al. (+10)
256 [GO] 2021―Jun―24 Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance Patrick J. Lenehan, Eshwan Ramudu, A.J. Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, et al. (+4)
257 [GO] 2021―Jun―24 ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion Qiangmin Zhang, Julia Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman
258 [GO] 2021―Jun―19 Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19 Marcel S. Woo, Friedrich Haag, Axel Nierhaus, Dominik Jarczak, Kevin Roedl, Christina Mayer, et al. (+14)
259 [GO] 2021―Jun―17 Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution Kalon J. Overholt, Jonathan R. Krog, Ivan Zanoni, Bryan D. Bryson
260 [GO] 2021―Jun―10 Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemic Guanlin Li, Shashwat Shivam, Michael E. Hochberg, Yorai Wardi, Joshua S. Weitz
261 [GO] 2021―Jun―10 CD177, a specific marker of neutrophil activation, is associated with COVID-19 severity and death Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17)
262 [GO] 2021―Jun―09 A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens Ebony N. Gary, Bryce M. Warner, Elizabeth M. Parzych, Bryan D. Griffin, Xizhou Zhu, Nikesh Tailor, et al. (+21)
263 [GO] 2021―Jun―01 Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain Chao Wu, Abraham J. Qavi, Asmaa Hachim, Niloufar Kavian, Aidan R. Cole, Austin B. Moyle, et al. (+10)
264 [GO] 2021―May―24 SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, et al. (+18)
265 [GO] 2021―May―18 Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci Chang Moon, Brian M. Schilder, Towfique Raj, Kuan-lin Huang
266 [GO] 2021―May―07 Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids Huaying Zhao, Di Wu, Ai Nguyen, Yan Li, Regina C. Adão, Eugene Valkov, et al. (+3)
267 [GO] 2021―May―01 Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, et al. (+21)
268 [GO] 2021―Apr―26 Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, Rajesh Abraham Jacob, Daniel Richard, Hassaan Maan, et al. (+22)
269 [GO] 2021―Apr―26 Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, et al. (+18)
270 [GO] 2021―Apr―21 Cell type resolved quantitative proteomics map of interferon response against SARS-CoV-2 Elisa Saccon, Xi Chen, Flora Mikaeloff, Jimmy Esneider Rodriguez, Laszlo Szekely, Beatriz Sá Vinhas, et al. (+7)
271 [GO] 2021―Apr―19 Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells Emi Sano, Sayaka Deguchi, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, et al. (+3)
272 [GO] 2021―Mar―19 Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, Sueva Cantalupo, Barbara Eleni Rosato, Ferdinando Bonfiglio, et al. (+15)
273 [GO] 2021―Mar―19 Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2 Ang Gao, Zhilin Chen, Assaf Amitai, Julia Doelger, Vamsee Mallajosyula, Emily Sundquist, et al. (+6)
274 [GO] 2021―Mar―14 The Silent Pandemic: Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2 Andrew R. Mahoney, Mohammad Moein Safaee, William M. Wuest, Ariel L. Furst
275 [GO] 2021―Mar―10 SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway Grant R. Campbell, Rachel K. To, Jonathan Hanna, Stephen A. Spector
276 [GO] 2021―Mar―10 Title: ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway Xiaoyuan Lin, Beibei Fu, Songna Yin, Zhifeng Li, Huawen Liu, Haiwei Zhang, et al. (+12)
277 [GO] 2021―Mar―07 A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection Jane E. Sinclair, Yanshan Zhu, Gang Xu, Wei Ma, Haiyan Shi, Kun-Long Ma, et al. (+9)
278 [GO] 2021―Mar―01 Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19 Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan A. Asangani
279 [GO] 2021―Feb―23 Heuristic Thinking and Altruism towards Machines in People Impacted by Covid-19 Celso M. de Melo, Jonathan Gratch, Frank Krueger
280 [GO] 2021―Feb―16 Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors Timothy S. Chang, Yi Ding, Malika K. Freund, Ruth Johnson, Tommer Schwarz, Julie M. Yabu, et al. (+6)
281 [GO] 2021―Feb―16 Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes Ziliang Zhou, Chunliu Huang, Zhechong Zhou, Zhaoxia Huang, Lili Su, Sisi Kang, et al. (+7)
282 [GO] 2021―Feb―10 Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz
283 [GO] 2021―Feb―07 Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy Wyler Emanuel, Mösbauer Kirstin, Franke Vedran, Diag Asija, Gottula Lina Theresa, Arsiè Roberto, et al. (+22)
284 [GO] 2021―Feb―06 Proteomic Investigation Reveals Dominant Alterations of Neutrophil Degranulation and mRNA Translation Pathways in COVID-19 Patients Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, et al. (+13)
285 [GO] 2021―Jan―28 Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity Alex Graudenzi, Davide Maspero, Fabrizio Angaroni, Rocco Piazza, Daniele Ramazzotti
286 [GO] 2021―Jan―22 The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule Christopher Szeto, Demetra S.M. Chatzileontiadou, Andrea T. Nguyen, Hannah Sloane, Christian A. Lobos, Dhilshan Jayasinghe, et al. (+5)
287 [GO] 2021―Jan―20 The outbreak of COVID-19 altered the relationship between current negative memory biases and future depressive degree in nonclinical depression Pengyu Zhang, Yi Piao, Ying Chen, Jiecheng Ren, Longhua Zhang, Bensheng Qiu, et al. (+2)
288 [GO] 2021―Jan―12 A high-throughput liquid bead-array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity Monique Bennett, Sandra Yoder, Eric Brady, Jill M. Pulley, Jillian P. Rhoads, Thomas G. Stewart, et al. (+4)
289 [GO] 2021―Jan―10 A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening Christoph Gorgulla, Krishna M. Padmanabha Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zi-Fu Wang, et al. (+31)
290 [GO] 2020―Dec―27 High-Throughput Rational Design of the Remdesivir Binding Site in the RdRp of SARS-CoV-2: Implications for Potential Resistance Aditya K. Padhi, Rohit Shukla, Prakash Saudagar, Timir Tripathi
291 [GO] 2020―Dec―16 Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections Simone A. Thair, Yudong D. He, Yehudit Hasin-Brumshtein, Suraj Sakaram, Rushika Pandya, Jiaying Toh, et al. (+13)
292 [GO] 2020―Dec―07 Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19 Lucy CK. Bell, Cem Meydan, Jacob Kim, Jonathan Foox, Daniel Butler, Christopher E. Mason, et al. (+3)
293 [GO] 2020―Dec―07 Structural characterization of Nonstructural protein 1 from SARS-CoV-2 Cameron Semper, Nobuhiko Watanabe, Alexei Savchenko
294 [GO] 2020―Nov―28 Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase Tyler L. Dangerfield, Nathan Z. Huang, Kenneth A. Johnson
295 [GO] 2020―Nov―25 SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain Leon Fodoulian, Joel Tuberosa, Daniel Rossier, Madlaina Boillat, Chenda Kan, Véronique Pauli, et al. (+5)
296 [GO] 2020―Nov―13 Innate and adaptive immunity of murine neural stem cell-derived piRNA exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus Bin Yu, Shoeb Ikhlas, Chunsheng Ruan, Xingxing Zhong, Dongsheng Cai
297 [GO] 2020―Oct―28 The SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and Furin proteases Lulin Zhou, Zubiao Niu, Xiaoyi Jiang, Zhengrong Zhang, You Zheng, Zhongyi Wang, et al. (+5)
298 [GO] 2020―Oct―26 Robust and specific secretory IgA against SARS-CoV-2 detected in human milk Alisa Fox, Jessica Marino, Fatima Amanat, Florian Krammer, Jennifer Hahn-Holbrook, Susan Zolla-Pazner, Rebecca L. Powell
299 [GO] 2020―Oct―05 Furin, a potential therapeutic target for COVID-19 Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, Mingxue Li, et al. (+10)
300 [GO] 2020―Oct―05 Impact of COVID-19 measures on short-term electricity consumption in the most affected EU countries and USA states Javier López Prol, Sungmin O
301 [GO] 2020―Oct―05 SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum Chiara Bruzzone, Maider Bizkarguenaga, Rubén Gil-Redondo, Tammo Diercks, Eunate Arana, Aitor García de Vicuña, et al. (+13)
302 [GO] 2020―Sep―29 Mitochondria - in the crossfire of SARS-CoV-2 and immunity Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire P. Millet
303 [GO] 2020―Sep―25 PPARγ cistrome repression during activation of lung monocyte-macrophages in severe COVID-19 Christophe Desterke, Ali G. Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
304 [GO] 2020―Sep―23 SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, Sofía Lage-Vickers, Rosario Lavignolle, Ayelén Toro, et al. (+6)
305 [GO] 2020―Sep―03 Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis Nilesh Kumar, Bharat Mishra, Adeel Mehmood, Mohammad Athar
306 [GO] 2020―Jul―31 ACE2, Metformin, and COVID-19 Atul Malhotra, Mark Hepokoski, Karen C. McCowen, John Y-J Shyy
307 [GO] 2020―Jul―28 The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3)
308 [GO] 2020―Jul―25 Molecular and immunological diagnostic tests of COVID-19 - current status and challenges Tugba Kilic, Ralph Weissleder, Hakho Lee
309 [GO] 2020―Jul―18 ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic Maya Braun, Elad Sharon, Irene Unterman, Maya Miller, Anna Mellul Shtern, Shmuel Benenson, et al. (+2)
310 [GO] 2020―Jun―20 Current status of COVID-19 therapies and drug repositioning applications Ozlem Altay, Elyas Mohammadi, Simon Lam, Hasan Turkez, Jan Boren, Jens Nielsen, et al. (+2)
311 [GO] 2020―Jun―20 CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 Roman Martin, Hannah F. Löchel, Marius Welzel, Georges Hattab, Anne-Christin Hauschild, Dominik Heider
312 [GO] 2020―Jun―09 Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9 Dene R. Littler, Benjamin S. Gully, Rhys N. Colson, Jamie Rossjohn
313 [GO] 2020―May―30 Mitigating coronavirus-induced acute respiratory distress syndrome by radiotherapy Jian Jian Li
314 [GO] 2020―May―28 Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker
315 [GO] 2020―May―13 The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3)
316 [GO] 2020―May―12 In the Race to Help with Covid-19, Time Is Precious: Editorial Guidelines for Coronavirus Papers Simona Fiorani, Stefano Tonzani
 [1] 

316 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.129 sec